These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 11761997

  • 1. [Hepatocellular carcinoma complicating Budd-Chiari syndrome].
    Kage M.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():478-81. PubMed ID: 11761997
    [No Abstract] [Full Text] [Related]

  • 2. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, Okamoto H.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [Abstract] [Full Text] [Related]

  • 3. Budd-Chiari syndrome and hepatocellular carcinoma.
    Kage M.
    J Gastroenterol; 2004 Jul; 39(7):706-7. PubMed ID: 15293149
    [No Abstract] [Full Text] [Related]

  • 4. [Chronic liver diseases and hepatocellular carcinoma].
    Dtsch Med Wochenschr; 1994 Mar 25; 119(12):443. PubMed ID: 8143566
    [No Abstract] [Full Text] [Related]

  • 5. [Epidemiology of hepatocellular carcinoma].
    Okuda K.
    Gan To Kagaku Ryoho; 1996 Aug 25; 23(9):1105-15. PubMed ID: 8751796
    [Abstract] [Full Text] [Related]

  • 6. [Risk factors of liver tumors].
    Fehér J, Lengyel G.
    Orv Hetil; 2004 Feb 15; 145(7 Suppl 1):365-7. PubMed ID: 15049052
    [Abstract] [Full Text] [Related]

  • 7. [Recurrence and prognosis of hepatitis C virus-related hepatocellular carcinoma--as compared with hepatitis B virus-related cases].
    Kobayashi S, Asano T, Saigoh K, Urashima T, Okazumi S, Abe Y, Takayama W, Isono K.
    Nihon Rinsho; 1995 Sep 15; 53 Suppl(Pt 1):810-4. PubMed ID: 7563881
    [No Abstract] [Full Text] [Related]

  • 8. [High risk group and screening methods of hepatocellular carcinoma].
    Matsushita E, Kaneko S, Kobayashi K.
    Nihon Rinsho; 2001 Oct 15; 59 Suppl 6():229-35. PubMed ID: 11761945
    [No Abstract] [Full Text] [Related]

  • 9. Budd-Chiari syndrome complicated by hepatocellular carcinoma with no evidence of infection with hepatitis virus: a case report.
    Kawaguchi T, Sata M, Ono N, Sakisaka S, Koga H, Ijuin H, Mitsuyama K, Ueno T, Kage M, Tanikawa K.
    Hepatogastroenterology; 1999 Oct 15; 46(30):3237-40. PubMed ID: 10626193
    [Abstract] [Full Text] [Related]

  • 10. Hepatocellular carcinoma.
    Kashyap AS, Kashyap S.
    Lancet; 1999 Jul 17; 354(9174):253. PubMed ID: 10421329
    [No Abstract] [Full Text] [Related]

  • 11. The epidemiology of hepatocellular carcinoma.
    Johnson PJ.
    Eur J Gastroenterol Hepatol; 1996 Sep 17; 8(9):845-9. PubMed ID: 8889448
    [Abstract] [Full Text] [Related]

  • 12. Epidemiology of hepatocellular carcinoma.
    Sherman M.
    Oncology; 2010 Jul 17; 78 Suppl 1():7-10. PubMed ID: 20616577
    [Abstract] [Full Text] [Related]

  • 13. Hepatocellular carcinoma: status in the era of liver transplantation.
    Singhal A, Jabbour N.
    J Okla State Med Assoc; 2009 Dec 17; 102(12):355-61. PubMed ID: 20131731
    [No Abstract] [Full Text] [Related]

  • 14. [Mass screening for high risk group of hepatocellular carcinoma].
    Kawanishi T, Mima S.
    Nihon Rinsho; 2001 Oct 17; 59 Suppl 6():786-90. PubMed ID: 11762057
    [No Abstract] [Full Text] [Related]

  • 15. Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia.
    Umoh NJ, Lesi OA, Mendy M, Bah E, Akano A, Whittle H, Hainaut P, Kirk GD.
    Liver Int; 2011 Feb 17; 31(2):215-21. PubMed ID: 21143369
    [Abstract] [Full Text] [Related]

  • 16. Hepatocellular carcinoma.
    Naugler WE, Schwartz JM.
    Dis Mon; 2008 Jul 17; 54(7):432-44. PubMed ID: 18570913
    [No Abstract] [Full Text] [Related]

  • 17. [Prevention of hepatocellular carcinogenesis by interferon].
    Ikeda K.
    Nihon Rinsho; 2001 Oct 17; 59 Suppl 6():755-63. PubMed ID: 11762051
    [No Abstract] [Full Text] [Related]

  • 18. Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country.
    Davídsdóttir L, Duberg AS, Törner A, Aleman S, Bäck E, Ekdahl K, Blaxhult A, Ekbom A, Hultcrantz R.
    Scand J Gastroenterol; 2010 Aug 17; 45(7-8):944-52. PubMed ID: 20384529
    [Abstract] [Full Text] [Related]

  • 19. Viral pathogenesis of hepatocellular carcinoma in the United States.
    Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER.
    Hepatology; 1993 Dec 17; 18(6):1326-33. PubMed ID: 8244256
    [Abstract] [Full Text] [Related]

  • 20. [Recurrence rates and prognosis after hepatectomy on the patients with hepatocellular carcinoma compromised with HCV hepatitis--comparison between B, BC and NBNC type].
    Une Y, Kamiyama T, Misawa K, Nakanishi K, Uchino J.
    Nihon Rinsho; 1995 Sep 17; 53 Suppl(Pt 1):815-20. PubMed ID: 7563882
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.